Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Heiq Plc LSE:HEIQ London Ordinary Share GB00BN2CJ299 ORD GBP0.30
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -0.71% 35.00 34.50 36.00 35.50 35.25 35.25 59,445 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 36.9 5.1 3.1 10.3 44

Heiq Share Discussion Threads

Showing 176 to 198 of 675 messages
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
14/2/2021
14:04
davemac3, there are a lot of aircraft parked up and deserted airports in a presently decimated travel industry that must be chomping at the bit to implement just a few of the 'End to End' possibilities and to get operating a full schedule of flights again. There have been rumours of HEIQ being in talks with airlines and it is one of the attractions that tempted me into investing. Virobloc is of definite relevance to all travel companies and on the airline industry. In the United Kingdom they have established PlaneTalking Products as their partner. One signature on the dotted line should unlock the potential.
hxxp://www.planetalking.net/sanitisation

leafysuburb
11/2/2021
11:38
They recently launched a product that survives 100 washes - this bettered their own previous version that lasted 30. Guess the detergent based may not last as long, but if you wash with that all the time it only needs to last until the next wash.

I'd consider 100 washes to be permanent. I doubt I wash anything more than that (particularly not whites) before replacing them.

dr biotech
11/2/2021
11:15
HEIQ VIROBLOCK IS PROVEN TO DESTROY VIRUSES IN TWO MINUTES
VIRUSES & BACTERIA CAN REMAIN ACTIVE ON TEXTILE SURFACES FOR DAYS – MONTHS!
UNIQUE & INNOVATIVE SWISS TECHNOLOGY FORMULATION – WORKS QUICKER AND LASTS LONGER THAN ANY OTHER ANTI-VIRAL PRODUCT – CAN LAST UP TO 2 MONTHS*
EFFECTIVE PROTECTION AGAINST CONTRACTION & TRANSMISSION OF VIRUSES & BACTERIA THAT USE TEXTILES AND OTHER SUBSTRATES AS HOSTING SURFACES
CAN BE INFUSED INTO TEXTILES SUCH AS BLANKETS, HEADREST COVERS, DUVETS, SLEEP SUITS ETC…
STRONG ECO CREDENTIALS – CERTIFIED AS SAFE & SUSTAINABLE AS THE INGREDIENTS ARE NATURAL, COSMETIC GRADE (INCI), BIO-BASED & RECYCLED
ONE OF THE FIRST TEXTILE TECHNOLOGIES IN THE WORLD TO BE PROVEN EFFECTIVE AGAINST SARS-CoV-2
IDEAL FOR AIRCRAFT DEEP CLEANS

jammytass
11/2/2021
11:13
An ongoing treatment rather than permanent.
miti 1000
11/2/2021
11:02
how long do the antiviral properties last? Is it something that could be put on airline seats, bus seats, train seats etc and provide permanent protection? Does it require retreatment? Does it wash or wear off?
davemac3
11/2/2021
10:22
Boros10,

Whilst I agree with the spin and your comments generally , Heiq is actually making a good profit on its revenues to date and seems to be capable of entering consumer markets. It deserves some leeway as it's concept stock rather than a value stock going forward.

At the same time, its valuation compares quite well against TSTL so there's plenty of mileage with HEIQ if they can deliver.

I look forward to hearing some concrete news from the British airlines whom HEIQ are negotiating with.

miti 1000
11/2/2021
10:13
the company is inundated re viro block enquiries
Hello

Thank you very much for your message.
Due to the numerous inquiries regarding our Viroblock technology, we currently need 1-2 days to respond to your message.

We thank you for your interest in our technology and thank you for your understanding.

Please send any inquiries regarding face masks to ppe@heiq.com

Kind Regards
Chris Piascinski

jammytass
11/2/2021
10:13
yeah - I think the news is all good but its the communication that needs some work. It comes across as a bit rampy which I believe (hope) is unnecessary.... and is certainly counter-productive. I am surprised that Arlington have not guided Carlo - maybe he knows what he wants and is not listening.

with the goal of moving from $30M to $300M 'in the medium term', I look forward to many more RNSs - but this is a good start!

one other thought - interesting he has named the major players - presumably the PR depts in those major players will pick up this - so is Carlo doing a bit of prospecting?

melody9999
11/2/2021
09:52
Perhaps its just me being a cynic. I get a bit wary of some figures being banded around by CEO's - or politicians. Mate of mine owns a chip shop and he said he's addressing the £100bn UK food market.

Having said that I'm a holder here and I do believe they are going places. May take some time to create sales, but if you want to add a antimicrobial to your washing powder then there is no better time to do it. I'd wash my labcoat with it.

dr biotech
11/2/2021
09:34
I agree Dr Biotech. I like HeiQ but I've noticed how it does like to talk about the hugeness of the various markets it is seeking to enter. Today it has spun a $1.5m contract spread over four years in the b2B detergent space, with a supplier generating only $182m in revenues, into a potential b2C opportunity in the broader $132bn detergents market.Better to under promise and over deliver. Carlo is definitely more Italian Swiss than German Swiss!
boros10
11/2/2021
09:06
To me, this has the potential to be another TSTL which made me a lot of money. There are plenty of hard surface cleaners but nothing that I'm aware of to treat clothes when washing or soft furnishings or to produce treated fabrics for manufacturing. Hospital laundries making the scrubs anti-bacterial and anti-virus or domestic washing at low temperatures. Huge market.
melton john
11/2/2021
08:18
Crikey, you are a tough crowd to please! Viroblock enters the laundry detergent market. For me the possibilities are significant. Why wouldn’t detergent makers want to license and use our technology to provide a safer enhanced detergent. Long term big winner IMO
rimau1
11/2/2021
07:59
Good bit of PR but not financially significant yet. Have to start somewhere.

Must admit I’m always a bit wary when companies state they are entering an £xxbn market, when it’s obviously not the addressable market. P&Gs turnover is 500x larger than their partners.

dr biotech
11/2/2021
07:44
nice contract win
jammytass
11/2/2021
07:41
Greenknigh1... 'Foot in the door' ;)
morkandmindy
11/2/2021
07:41
True, but it has the potential to go far further than that. It's a whole new market potentially being opened up.
dibbs
11/2/2021
07:26
Contract worth £270k per year in revenue at the moment. Hardly worth mentioning.
greenknight1
11/2/2021
07:07
Nice, could be huge if it takes off
davemac3
06/2/2021
12:40
Looks like the chart has shown a bottom Should start to rise back now
2bluelynn
29/1/2021
06:28
Prodough, that is spot on.
miti 1000
28/1/2021
23:46
actually if you add back (one off)listing costs of $3.7M in H2, profit is $6.3M or 33% of revenue. this compares with H1 at 36%. so listing costs explain most of the reason that op profit is inline but revenue ahead.
melody9999
28/1/2021
22:00
Dr biotech, they have told you why revenues are ahead but op profit inline. Maybe they just assumed people investing in their company would be able to understand basic accounting?! R&D costs for new products are front loaded. That is, you have to spend money and incur costs developing them before you sell any. This has an impact on operating profit margins in those years where r&d is a focus for future growth. They have said many times that they have new products to launch this year. Do you think they just go in a room, have an idea and launch a new product next week? If you want to invest in growth stocks you have to accept the need for management to invest upfront to achieve that growth. Otherwise we may as well go buy utility stocks.
prodough
28/1/2021
19:55
I agree. Numbers would have helped. They said:

Revenue for FY 2020 exceeded market expectations.
Operating profit for FY 2020 in line with market expectations,
Trading for the current year 2021 in line with market expectations.

I know you can read too much into these things, but I struggle to reconcile revenue exceeding expectations, but profit & current trading "only" inline. Sounds like a one off revenue leap that never made it to the bottom line due to unforeseen circumstances. R&D costs shouldn’t had leaped since the IPO was only two months ago.

I suppose all will become clear when they give the figures.

But a bit of a fluff PR-RNS doesn't hurt occasionally. Can wash your masks etc 100 times and it'd still work. Sounds impressive.

dr biotech
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
Your Recent History
LSE
HEIQ
Heiq
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 05:10:08